178 related articles for article (PubMed ID: 22034893)
21. Correlation between p38 mitogen-activated protein kinase and human telomerase reverse transcriptase in sarcomas.
Matsuo T; Shimose S; Kubo T; Fujimori J; Yasunaga Y; Sugita T; Ochi M
J Exp Clin Cancer Res; 2012 Jan; 31(1):5. PubMed ID: 22243975
[TBL] [Abstract][Full Text] [Related]
22. Malignant fibrous histiocytoma and fibrosarcoma of bone: a re-assessment in the light of currently employed morphological, immunohistochemical and molecular approaches.
Romeo S; Bovée JV; Kroon HM; Tirabosco R; Natali C; Zanatta L; Sciot R; Mertens F; Athanasou N; Alberghini M; Szuhai K; Hogendoorn PC; Dei Tos AP
Virchows Arch; 2012 Nov; 461(5):561-70. PubMed ID: 23001328
[TBL] [Abstract][Full Text] [Related]
23. CD99 immunoreactivity in atypical fibroxanthoma and pleomorphic malignant fibrous histiocytoma: a useful diagnostic marker.
Hartel PH; Jackson J; Ducatman BS; Zhang P
J Cutan Pathol; 2006 Sep; 33 Suppl 2():24-8. PubMed ID: 16972949
[TBL] [Abstract][Full Text] [Related]
24. Malignant fibrous histiocytoma of bone: A survival analysis from the National Cancer Database.
Malik AT; Baek J; Alexander JH; Voskuil RT; Khan SN; Scharschmidt TJ
J Surg Oncol; 2020 Jun; 121(7):1097-1103. PubMed ID: 32133661
[TBL] [Abstract][Full Text] [Related]
25. The role of MAPK pathway in bone and soft tissue tumors.
Sasaki K; Hitora T; Nakamura O; Kono R; Yamamoto T
Anticancer Res; 2011 Feb; 31(2):549-53. PubMed ID: 21378337
[TBL] [Abstract][Full Text] [Related]
26. Histiocyte-like cells expressing factor XIIIa do not belong to the neoplastic cell population in malignant fibrous histiocytoma.
Szollosi Z; Nemeth T; Egervari K; Nemes Z
Pathol Res Pract; 2005; 201(5):369-77. PubMed ID: 16047946
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of the hepatocyte growth factor (HGF) receptor (Met) and presence of a truncated and activated intracellular HGF receptor fragment in locally aggressive/malignant human musculoskeletal tumors.
Wallenius V; Hisaoka M; Helou K; Levan G; Mandahl N; Meis-Kindblom JM; Kindblom LG; Jansson JO
Am J Pathol; 2000 Mar; 156(3):821-9. PubMed ID: 10702398
[TBL] [Abstract][Full Text] [Related]
28. Adipogenic, osteogenic and myofibrogenic differentiations of a rat malignant fibrous histiocytoma (MFH)-derived cell line, and a relationship of MFH cells with embryonal mesenchymal, perivascular and bone marrow stem cells.
Yamate J; Ogata K; Yuasa T; Kuwamura M; Takenaka S; Kumagai D; Itoh K; LaMarre J
Eur J Cancer; 2007 Dec; 43(18):2747-56. PubMed ID: 18036812
[TBL] [Abstract][Full Text] [Related]
29. Malignant fibrous histiocytoma of the floor of mouth: a case report and review of the literature.
Wu Y; Liu X; Lv Y; Li Z
J Stomatol Oral Maxillofac Surg; 2022 Jun; 123(3):e106-e111. PubMed ID: 34224923
[TBL] [Abstract][Full Text] [Related]
30. Functional genomics identifies AMPD2 as a new prognostic marker for undifferentiated pleomorphic sarcoma.
Orth MF; Gerke JS; Knösel T; Altendorf-Hofmann A; Musa J; Alba-Rubio R; Stein S; Hölting TLB; Cidre-Aranaz F; Romero-Pérez L; Dallmayer M; Baldauf MC; Marchetto A; Sannino G; Knott MML; Wehweck F; Ohmura S; Li J; Hakozaki M; Kirchner T; Dandekar T; Butt E; Grünewald TGP
Int J Cancer; 2019 Feb; 144(4):859-867. PubMed ID: 30267407
[TBL] [Abstract][Full Text] [Related]
31. Comparison of Features and Outcomes of Undifferentiated Pleomorphic Sarcoma of Bone and Soft Tissue.
Gusho CA; Lee L; Guntin J; Blank AT
J Surg Res; 2022 Feb; 270():313-320. PubMed ID: 34731728
[TBL] [Abstract][Full Text] [Related]
32. Undifferentiated pleomorphic sarcoma with co-existence of KRAS/PIK3CA mutations.
Li B; Li L; Li X; Wang Y; Xie Y; Liu C; Li F
Int J Clin Exp Pathol; 2015; 8(7):8563-7. PubMed ID: 26339434
[TBL] [Abstract][Full Text] [Related]
33. Identification of sequence polymorphisms in the D-loop region of mitochondrial DNA as risk biomarkers for malignant fibrous histiocytoma.
Xun J; Li Z; Song X; Wang X
Mitochondrial DNA; 2015 Jun; 26(3):380-3. PubMed ID: 24083973
[TBL] [Abstract][Full Text] [Related]
34. Malignant fibrous histiocytoma of visceral organs: clinicopathologic features and diagnostic value of ezrin and HMG-CoA reductase.
Gu J; Zhang S; Wu X; Shi J; Zhang B; Zhang X; Yang J; Obulkasim H; Duan F; Deng C; He J; Zou X; Ding Y
Int J Clin Exp Pathol; 2015; 8(3):2876-87. PubMed ID: 26045796
[TBL] [Abstract][Full Text] [Related]
35. RAS/MAPK pathway hyperactivation determines poor prognosis in undifferentiated pleomorphic sarcomas.
Serrano C; Romagosa C; Hernández-Losa J; Simonetti S; Valverde C; Moliné T; Somoza R; Pérez M; Vélez R; Vergés R; Domínguez R; Carles J; Ramón Y Cajal S
Cancer; 2016 Jan; 122(1):99-107. PubMed ID: 26479291
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathological characteristics and survival of malignant fibrous histiocytoma of the bone: A population-based study using the SEER database.
Liu B; Wei H; Ren YJ; Zou D; Zhang K; Ma Q; Xiao X
PLoS One; 2020; 15(6):e0232466. PubMed ID: 32492019
[TBL] [Abstract][Full Text] [Related]
37. Establishment and characterization of NCC-UPS3-C1: a novel patient-derived cell line of undifferentiated pleomorphic sarcoma.
Tsuchiya R; Yoshimatsu Y; Noguchi R; Sin Y; Ono T; Akiyama T; Sugaya J; Nakatani F; Kojima N; Yoshida A; Ohtori S; Kawai A; Kondo T
Hum Cell; 2022 Jan; 35(1):384-391. PubMed ID: 34665443
[TBL] [Abstract][Full Text] [Related]
38. Role of matrix metalloproteinase (MMP) 2 and MMP-9 in soft tissue sarcoma.
Yang HK; Jeong KC; Kim YK; Jung ST
Clin Orthop Surg; 2014 Dec; 6(4):443-54. PubMed ID: 25436070
[TBL] [Abstract][Full Text] [Related]
39. Frequent expression of smooth muscle markers in malignant fibrous histiocytoma of bone.
Ueda T; Araki N; Mano M; Myoui A; Joyama S; Ishiguro S; Yamamura H; Takahashi K; Kudawara I; Yoshikawa H
J Clin Pathol; 2002 Nov; 55(11):853-8. PubMed ID: 12401825
[TBL] [Abstract][Full Text] [Related]
40. Identifying actionable variants using next generation sequencing in patients with a historical diagnosis of undifferentiated pleomorphic sarcoma.
Lewin J; Garg S; Lau BY; Dickson BC; Traub F; Gokgoz N; Griffin AM; Ferguson PC; Andrulis IL; Sim HW; Kamel-Reid S; Stockley TL; Siu LL; Wunder JS; Razak ARA
Int J Cancer; 2018 Jan; 142(1):57-65. PubMed ID: 28891048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
